-
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Given Average Recommendation of "Moderate Buy" by Analysts
来源: Buzz FX / 14 3月 2025 01:56:16 America/Chicago
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Given Average Recommendation of "Moderate Buy" by Analysts Written by MarketBeat March 14, 2025 Share Link copied to clipboard. Remove Ads Shares of Kymera Therapeutics, Inc.
Read more...